Clinical Trial

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describe real-world treatment approaches and clinical outcomes among adults with acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) in routine clinical practice in Russia.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-11-18; most recent amendment 2026-07-13.
Status change: Not Yet Recruiting → Recruiting 2026-01-12
Trial Details
NCT Number NCT07247279
Lead Sponsor AstraZeneca
Conditions Rare Diseases, Generalized Myasthenia Gravis (gMG)
Enrollment 450 participants
Start Date 2025-12-23
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12